Peter S. Conti , MD, PhD

Research Interests

Dr. Conti is board certified in Nuclear Medicine specializing in diagnostic imaging applications in oncology. He is an expert in the clinical use of positron emission tomography (PET) in the diagnosis, staging and treatment monitoring of cancer. His research interests include the development of new radiolabeled imagining agents for use in the diagnosis of cancer and infectious disease and evaluation of the effects of gene therapy on tumors.

Clinical Interests

Diagnostic Radiology
Oncology applications of positron emission tomography
Nuclear Radiology
PET Imaging
BioImaging

Degrees

Cornell University, PHD, 1985
Cornell University Medical College, MD, 1985

Internships

St. Lukes Hospital; Surgery, 1985 - 1986

Residencies

Johns Hopkins Hospital - Radiology, 1986 - 1989

Fellowships

Johns Hopkins Hospital - Nuclear Medicine, 1990 - 1991

Board Certification

American Board of Radiology, 1992
American Board of Nuclear Medicine, 1991

Memberships

Society of Nuclear Medicine
American College of Radiology
American College of Nuclear Physicians

Clinical Affiliation

USC Care Medical Group
USC University Hospital
USC/Norris Cancer Hospital

Conti, PS, Sordillo PP, Sordillo EM, and Schmall B. Tumor localization of the metabolically trapped radiolabeled substrates 2-deoxy-D-glucose and aminocyclopentanecarboxylic acid in human melanoma heterotransplants. Amer J Clin Oncol 9: 537-540, 1986.

Conti PS, Keppler J and Halls JM. Positron emission tomography: A financial and operational analysis. Amer J Roentg 162: 1279-1286, 1994.

Conti PS, Alauddin MM, Fissekis J, Schmall B and Watanabe KA. Synthesis of carbon-11 labeled 2'-fluoro-5-methyl-1-D-arabinofuranosyluracil (FMAU): A potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl Med Biol 22: 783-789, 1995

Conti PS, Lilien DL, Grafton ST, Bading JR, Keppler J and Hawley K. PET and (18F)-FDG: A clinical update. Nucl Med Biol 23: 717-735, 1996

Powars DR, Conti pS, Wong W-Y, Groncy P, Hyman C, Smoth E, Ewing N, Keenan RR, Zee C-S, Harold Y, Hiti A, Teng E, Chan LS. Cerebra vasculopathy in sickle cell anemia: Diagnostic utility of positron emission tomography (PET) and magnetic resonance imaging (MRI). Blood 93: 1-10, 1999.